openPR Logo
Press release

Stomach Cancer Treatment Market Growth Factors, Regional Overview, Competitive Strategies And Forecast Up To 2030

07-26-2022 09:47 AM CET | Health & Medicine

Press release from: Growth Plus Reports

Stomach Cancer Treatment Market

Stomach Cancer Treatment Market

According to the deep-dive market assessment study by Growth+ Reports, the global stomach cancer treatment market is estimated at ~US$ 2.45 billion in 2021. The market is expected to witness a CAGR of ~ 14.70 % from 2022 to 2030.

After smoking and drinking, obesity is the major cause of all types of gastric cancer, with rapid increase in obesity, risk of stomach cancer is also increasing correspondingly. Overweight leads to gastrointestinal cancer that have three main characteristics, abnormality in insulin signaling, chronic low-grade infection, and metabolism of sex hormones. A report from IARC (International Agency for Research in Cancer) suggested that excessive body fat can lead to sixteen or more types of cancer, which makes obesity the second most prominent cause of cancer after smoking. According to the IARC and the World Cancer Research Fund (WCRF), excess adiposity is a cause or a probable risk factor for gastrointestinal malignancies, including those of the pancreas, liver, oesophagus, stomach, and gallbladder. This report also states that the reduction in body fat can reduce the risk of gastrointestinal cancers.

The global stomach cancer treatment Market has been divided into four regions: North America, Europe, Asia Pacific, and the Rest of the World (RoW). Due to large prevalence of stomach cancer in the Asia Pacific, this region has dominated the global stomach cancer treatment market. North America is also significantly contributing to the global stomach cancer treatment market due to a high number of patients, unhealthy eating habits, increased consumption of alcohol and tobacco, and also a large pool of geriatric population.

Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request-sample/stomach-cancer-treatment-market/7734

Key Players Mentioned in the Global Stomach Cancer Treatment Market Research Report:

• Eli Lilly and Company
• Novartis International AG
• Merck & Co. Inc.
• F. Hoffman La-Roche Ltd.
• Otsuka Pharmaceutical Co. Ltd
• Bayer AG
• Celltrion Inc.
• Tahio Pharmaceutical Co. Ltd.
• Bristol-Myers Squibb Co.
• Ipsen pharma S.A.

Global Stomach Cancer Treatment Market Segmentation by Treatment Type:

• Chemotherapy
• Radiotherapy
• Immunotherapy
• Targeted Drug Therapy
• Surgery

Global Stomach Cancer Treatment Market Segmentation by End User:

• Hospitals and Clinics
• Specialized Cancer Treatment Centers
• Ambulatory Surgical Centers

Key Reasons to Purchase:

To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the Stomach Cancer Treatment Market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the outlook and prospects for the market.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Stomach Cancer Treatment Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Stomach Cancer Treatment Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

(6) What are the market opportunities and threats faced by vendors in the Global Stomach Cancer Treatment Market?

Detailed TOC of Global Stomach Cancer Treatment Market Growth (Status and Outlook) 2022-2030

1 Scope of the Report

1.1 Market Ecosystem
1.2 Geographic Scope
1.3 Timeline Under Consideration
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Stomach Cancer Treatment Market Executive Summary

2.1 World Market Overview
2.1.1 Global Market Size 2022-2030
2.1.2 Market Size CAGR by Region 2020 VS 2028
2.2 Stomach Cancer Treatment Market Segment by Type
2.2.1 Type 1
2.2.2 Type 2

Browse the full report now: https://growthplusreports.com/report/stomach-cancer-treatment-market/7734

Manan Sethi
Director, Market Insights
Email: enquire@growthplusreports.com
Phone no: +91 96545 76783
Web: https://growthplusreports.com/

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stomach Cancer Treatment Market Growth Factors, Regional Overview, Competitive Strategies And Forecast Up To 2030 here

News-ID: 2689299 • Views:

More Releases from Growth Plus Reports

Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation Therapies Redefining Treatment
Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation T …
Newark, New Castle, USA: The "Germ Cell Tumor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Germ Cell Tumor Market: https://www.growthplusreports.com/report/germ-cell-tumor-market/8949 This latest report researches the industry structure,
Atypical Hemolytic Uremic Syndrome Treatment Market - Revolutionizing AHUS Care: Next-Generation Therapies Leading the Way
Atypical Hemolytic Uremic Syndrome Treatment Market - Revolutionizing AHUS Care: …
Newark, New Castle, USA: The "Atypical Hemolytic Uremic Syndrome Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Atypical Hemolytic Uremic Syndrome Treatment Market: https://www.growthplusreports.com/report/atypical-hemolytic-uremic-syndrome-treatment-market/8948 This latest report
Adenine Phosphoribosyltransferase Deficiency Therapeutics Market - Lighting the Path to Relief: APRT Therapeutics Paving the Way
Adenine Phosphoribosyltransferase Deficiency Therapeutics Market - Lighting the …
Newark, New Castle, USA: The "Adenine Phosphoribosyltransferase Deficiency Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Adenine Phosphoribosyltransferase Deficiency Therapeutics Market: https://www.growthplusreports.com/report/adenine-phosphoribosyltransferase-deficiency-therapeutics-market/8946 This latest report researches the
Mycobacterium Bovis Treatment Market - Revolutionizing Mycobacterium Bovis Treatment: Breakthroughs in Combating the Infection
Mycobacterium Bovis Treatment Market - Revolutionizing Mycobacterium Bovis Treat …
Newark, New Castle, USA: The "Mycobacterium Bovis Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Mycobacterium Bovis Treatment Market: https://www.growthplusreports.com/report/mycobacterium-bovis-treatment-market/8945 This latest report researches the industry structure,

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For